• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION, ASHITAKA CAPIOX RX OXYGENATOR; OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION, ASHITAKA CAPIOX RX OXYGENATOR; OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Catalog Number CX*RX25RW
Device Problem Filtration Problem (2941)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 11/25/2017
Event Type  Injury  
Manufacturer Narrative
The actual device was discarded by the involved facility.Therefore, a factory retained sample from the reported product code/lot number combination was evaluated.Visual inspection confirmed the retention sample had no anomalies.Bovine blood was circulated in the retention sample.No anomalies were found that would trigger a clot formation.The provided images of the actual sample were reviewed; it was difficult however to confirm the presence of the reported clots inside the device.A review of the device history record and shipping inspection record from the reported product code/lot number combination was conducted with no relevant findings.The investigation verified the retention sample was the normal product.With no returned of the actual device the exact cause of the reported event cannot be definitively determined based on the available information.(b)(4).
 
Event Description
The user facility reported clots were found in the reported device.During an cabg, avr case, it started with a beating heart cabg, the perfusionist used primed pump (oxygenator) to collect shed blood into the reservoir, after 30 minutes the perfusionist found clots in the reservoir.Patients act- 528/640 secs.Heparin was added when priming.Perfusionist changed the oxygenator before performing the bypass, there was no harm to the patient.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAPIOX RX OXYGENATOR
Type of Device
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomiya city, shizuoka 418
JA  418
Manufacturer (Section G)
TERUMO CORPORATION, ASHITAKA
reg. no. 9681834
150 maimaigi-cho
fujinomiya city, shizuoka 418
JA   418
Manufacturer Contact
terry callahan
reg. no. 2243441
2101 cottontail ln.
somerset, NJ 08873
8002837866
MDR Report Key7138382
MDR Text Key95504838
Report Number9681834-2017-00250
Device Sequence Number1
Product Code DTZ
UDI-Device Identifier04987350769572
UDI-Public04987350769572
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
K040210
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other
Type of Report Initial
Report Date 12/21/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/21/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/30/2020
Device Catalogue NumberCX*RX25RW
Device Lot Number170715
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received11/25/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/15/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-